Dance Biopharm withdraws its initial public offering of common stock

Company says it may conduct a subsequent private offering of its stock

By Devika Patel

Knoxville, Tenn., Oct. 16 – Dance Biopharm, Inc. canceled plans for its initial public offering of its common stock, according to a registration withdrawal filed Thursday with the Securities and Exchange Commission. The deal was announced April 9.

The company said it might conduct a subsequent private offering of its stock.

The biopharmaceutical company is based in Brisbane, Calif.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.